Type 2 Diabetes

Researchers explored seasonal variations in hypoglycemia and compared differences in type 1 diabetes and type 2 diabetes.

The latest United States Preventive Service Task Force screening guidelines for diabetes, released in October 2015, miss 55% of high-risk individuals with prediabetes or diabetes, a new study shows.

Family members of diabetics can be stressed by worry, wondering what to do about a hypoglycemic attack or fretting over the patient's job security. A new study looks at the impact of diabetes on these caregivers.

Diabetics who need CABG surgery have better outcomes when surgeons perform total arterial revascularization.

Analysis of adult diabetics between 1998 and 2014 has found a significant shift in how kidney disease presents itself, a shift that may have implications for both diagnoses and treatment.

Our August list of news and research includes research concerning a sedentary lifestyle, FDA updates, and imaging after thyroid cancer treatment.

A team from Philadelphia set out to uncover visual outcomes associated with switching to aflibercept from bevacizumab or ranibizumab.

Researchers from three institutions in Illinois collaborated to examine real world visual outcomes for people with wet age-related macular degeneration (AMD) on anti-vascular endothelial growth factor (VEGF) drugs.

In a poster presentation at the 34th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS 2016) in San Francisco, California, researchers looked at how patients responded to telemedicine in ophthalmology.

Despite established criteria for patients at risk for vision-threatening diabetic retinopathy from the United Kingdom Prospective Diabetes Study (UKPDS), referral rates don’t reflect the number of people who should visit optometrists, ophthalmologists, and retina specialists.

It’s been unclear whether statins affect the development of diabetic microvascular complications, therefore, Alam Park, MD, from the Ajou University School of Medicine in Korea, and colleagues set out to uncover just that.

SGLT2 inhibition has been shown to preserve renal function and decrease albuminuria in animal models, but do these results apply to humans?

A new meta-analysis delved further into the topic of fracture risk with SGLT2 inhibitors. Was new evidence uncovered?

“Our study has taken us to the most complete understanding yet of the genetic architecture of type 2 diabetes,” say the researchers.

Preventing complications of diabetes is much more desirable than dealing with them once they develop. Our blogger offers tips on diabetic neuropathy.

Does butter deserve its bad rap? A meta-analysis examines butter consumption and type 2 diabetes, as well as mortality and cardiovascular disease.

The Mediterranean diet has been linked to decreased risk of metabolic syndrome, diabetes, and CV events, but there is also criticism of these studies.

Why do adolescents with type 1 diabetes fail to meet the international HbA1c treatment target? What can be done to overcome treatment barriers?

Following extensive clinical trials, the FDA today announced its approval of Adlyxin (lixisenatide), a once-daily injection for glycemic control. Adlyxin is a hormone that works to normalize blood sugar levels, and could be a treatment option for the well-over 25 million Americans living with Type 2 diabetes.

Investigators explored the use of bedtime and morning blood glucose values to address postprandial control issues in patients with type 2 diabetes.

While the influenza vaccine has endured its fair share of controversy, new research shed light on one of the flu shot’s added benefits: diabetes patients who get the vaccine may not suffer as many cardiovascular or respiratory problems.

A new meta-analysis of 102 randomized controlled diet trials found that consumption of polyunsaturated fat instead of carbohydrate or saturated fat reduces blood sugar levels and insulin resistance while also increasing the body’s ability to make insulin.

The annual meeting of the American Diabetes Association provided many studies looking at the condition from a variety of angles. What doctors did with those results when they went back to their practices was up to them.

What were the pros and cons of a transplanted human pancreatic islets product in patients with type 1 diabetes and impaired awareness of hypoglycemia?

As patients with diabetes progress throughout their lives there may be a need to increase treatment to help manage their symptoms. A recent study looked at how likely patients are to intensify their treatment and what that can mean for their care.

Follow-up data from the landmark Diabetes Prevention Study examined the role of physical activity in diabetes prevention.

Patients in the open-label extension phase of RIDE/RISE who needed Lucentis less frequently tended to have less advanced diabetic macular edema (DME) at extension baseline and to respond better to initial treatment, according to post hoc analysis. These results suggest that earlier treatment of center-involving DME with loss of visual acuity may decrease its long-term treatment burden.

Patients with diabetes face many challenges over the course of a day, not the least of which is ensuring their blood glucose levels stay in a safe range. Technological advances have helped make this an easier obstacle to overcome.

While technology is helping patients with diabetes improve their quality of life there is only so much that technology and their health care providers can do for them. In many ways a patient can and must now play a larger role in their overall care.

With so many patients dealing with diabetes on a daily basis the burden of trying to help can be too much for even the biggest and most advanced companies. By working together they can not only reach more patients but also provide a higher level of care.